Efficient early and sustained transduction of human fetal mesencephalon using adeno-associated virus type 2 vectors

Cell Transplantation

Volumn 13, Issue 5, 2004, Pages 565-571

  Tenenbaum, Liliane ^a,b,d   Peschanski, M ^c   Melas, C ^a,b   Rodesh, F ^a   Lehtonen, E ^a,b   Stathopoulos, A ^a,b   Velu, T ^b   Brotchi, J ^a   Levivier, M ^a  

^a ERASME HOSPITAL   (Belgium)

^b UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^c HENRI MONDOR HOSPITAL   (France)

^d IRIBHM   (Belgium)

Author keywords

Adeno associated virus (AAV); Dopaminergic grafts; Fetal mesencephalon; Parkinson's disease; Transplantation

Indexed keywords

ADENOVIRUS VECTOR; CASPASE INHIBITOR; GREEN FLUORESCENT PROTEIN; GROWTH FACTOR;

ADENOVIRUS 2; ARTICLE; CELL CULTURE; CELL SURVIVAL; CONTROLLED STUDY; CYTOMEGALOVIRUS; DNA MODIFICATION; EMBRYO; FETAL TISSUE TRANSPLANTATION; FETUS; GENE EXPRESSION; GRAFT SURVIVAL; HUMAN; HUMAN TISSUE; MESENCEPHALON; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; PRIORITY JOURNAL; PROMOTER REGION; PUTAMEN; REINNERVATION; REPORTER GENE; VIRAL GENE DELIVERY SYSTEM;

ADENO-ASSOCIATED VIRUS; ADENO-ASSOCIATED VIRUS 2; ADENOVIRIDAE; ANIMALIA; CUCUMBER MOSAIC VIRUS; CYTOMEGALOVIRUS; HUMAN ADENOVIRUS TYPE 2;

EID: 9344264643     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.3727/000000004783983684     Document Type: Article

References (45)

1. Arsenijevic, Y.; Villemure, J. G.; Brunei, J. F.; Bloch, J. J.; Deglon, N.; Kostic, C.; Zurn, A.; Aebischer, P. Isolation of multipotent neural precursors residing in the cortex of the adult human brain. Exp. Neurol. 170:48-62; 2001.
2. Barker, R. A.; Dunnett, S. B.; Faissner, A.; Fawcett, J. W. The time course of loss of dopaminergic neurons and the gliotic reaction surrounding grafts of embryonic mesencephalon to the striatum. Exp. Neurol. 141:79-93; 1996.
3. Barker, R. A.; Dunnett, S. B. Functional integration of neural grafts in Parkinson's disease. Nat. Neurosci. 2:1047-1048; 1999.
4. Bartlett, J. S.; Samulski, R. J.; McCown, T. J. Selective and rapid uptake of adeno-associated virus type 2 in brain. Hum. Gene Ther. 9:1181-1186; 1998.
5. Bilang-Bleuel, A.; Revah, F.; Colin, P.; Locquet, I.; Robert, J. J.; Mallet, J.; Horellou, P. Intrastriatal injection of an adenoviral vector expressing glial-cell-line-derived neurotrophic factor prevents dopaminergic neuron degeneration and behavioural impairment in a rat model of Parkinson disease. Proc. Natl. Acad. Sci. USA 94:8818-8823; 1997.
6. Björklund, A. Neural transplantation: An experimental tool with clinical possibilities. Trends Neurosci. 14:319-322; 1991.
7. Bolam, J. P.; Freund, T. F.; Björklund, A.; Dunnett, S. B.; Smith, A. D. Synaptic input and local output of dopaminergic neurons in grafts that functionally reinnervate the host striatum. Exp. Brain Res. 68:131-146; 1987.
8. Brundin, P.; Barbin, G.; Strecker, R. E.; Isacson, O.; Prochiantz, A.; Björklund, A. Survival and function of dissociated rat dopamine neurons grafted at different developmental stages or after being cultured in vitro. Dev. Brain Res. 39:233-243; 1988.
9. Brundin, P.; Odin, P.; Gustavii, B.; Frackowiak, R.; Leenders, K. L.; Sawle, G.; Rothwell, J. C. Transplantation of fetal dopamine neurons in Parkinson's disease: One-year clinical and neurophysiological observations in two patients with putaminal implants. Ann. Neurol. 31:155-165; 1992.
10. Buchet, D.; Serguera, C.; Zennou, V.; Chameau, P.; Mallet, J. Long-term expression of beta-glucuronidase by genetically modified human neural progenitor cells grafted into the mouse central nervous system. Mol. Cell. Neurosci. 19:389-401; 2002.
11. Collier, T. J.; Sortwell, C. E.; Daley, B. F. Diminished viability, growth, and behavioural efficacy of fetal dopamine neuron grafts in aging rats with long-term dopamine depletion: An argument for neurotrophic supplementation. J. Neurosci. 19:5563-5573; 1999.
12. Du, B.; Wu, P.; Boldt-Houle, D. M.; Terwilliger, E. F. Efficient transduction of human neurons with an adeno-associated virus vector. Gene Ther. 3:254-261; 1996.
13. Fan, D.; Ogawa, M.; Ikeguchi, K.; Fujimoto, K.; Urabe, M.; Kume, A.; Nishizawa, M.; Matsushita, N.; Kiuchi, K.; Ichinose, H.; Nagatsu, T.; Kurtzman, G. J.; Nakano, I.; Ozawa, K. Prevention of dopaminergic neuron death by adeno-associated virus vector-mediated GDNF gene transfer in rat mesencephalic cells in vitro. Neurosci. Lett. 248:61-64; 1998.
14. Freese, A.; Kaplitt, M. G.; O'Connor, W. M.; Abbey, M.; Langer, D.; Leone, P.; O'Connor, M. J.; During, M. J. Direct gene transfer into human epileptogenic hippocampal tissue with an adeno-associated virus vector: Implications for a gene therapy approach to epilepsy. Epilepsia 38:759-766; 1997.
15. Freund, T. F.; Bolam, J. P.; Björklund, A.; Stenevi, U.; Dunnett, S. B.; Powell, J. F.; Smith, A. D. Efferent connections of grafted dopaminergic neurons reinnervating the host neostriatum: A tyrosine hydroxylase immunocytochemical study. J. Neurosci. 5:603-616; 1985.
16. Goggi, J.; Theofilopoulos, S.; Riaz, S. S.; Jauniaux, E.; Stern, G. M.; Bradford, H. F. The neuronal survival effects of rasagiline and deprenyl on fetal human and rat ventral mesencephalic neurones in culture. Neuroreport 11:3937-3941; 2000.
17. Grimm, D.; Kern, A.; Rittner, K.; Kleinschmidt, J. A. Novel tools for production and purification of recombinant adeno-associated virus vectors. Hum. Gene Ther. 9:2745-2760; 1998.
18. Hauser, R. A.; Freeman, T. B.; Snow, B. J.; Nauert, M.; Gauger, L.; Kordower, J. H.; Olanow, C. W. Long-term evaluation of bilateral fetal nigral transplantation in Parkinson disease. Arch. Neurol. 56:179-187; 1999.
19. Karlsson, J.; Love, R. M.; Clarke, D. J.; Brundin, P. Effects of anaestehetics and lazaroid U-83836E on survival of transplanted rat dopaminergic neurones. Brain Res. 13:546-550; 1999.
20. Keir, S. D.; Miller, J.; Yu, G.; Hamilton, R.; Samulski, R. J.; Xiao, X.; Tornatore, C. Efficient gene transfer into primary and immortalized human fetal glial cells using adeno-associated virus vectors: Establishment of a glial cell line with a functional CD4 receptor. J. Neurovirol. 3(5): 322-330; 1997.
21. Kirik, D.; Rosenblad, C.; Björklund, A.; Mandel, R. J. Long-term rAAV-mediated gene transfer of GDNF in the rat Parkinson's model: Intrastriatal but not intranigral transduction promotes functional regeneration in the lesioned nigrostriatal system J. Neurosci. 20:4686-4700; 2000.
22. Klein, R. L.; Meyer, E. M.; Peel, A. L.; Zolotukhin, S.; Meyers, C.; Muzyczka, N.; King, M. A. Neuron-specific transduction in the rat septohippocampal or nigrostriatal pathway by recombinant adeno-associated virus vectors. Exp. Neurol. 150:183-194; 1998.
23. Kordower, J. H.; Freeman, T. B.; Snow, B. J.; Vingerhoets, F. J.; Mufson, E. J.; Sanberg, P. R.; Hauser, R. A.; Smith, D. A.; Nauert, G. M.; Perl, D. P. Neuropathological evidence of graft survival and striatal reinnervation after the transplantation of fetal mesencephalic tissue in a patient with Parkinson's disease. N. Engl. J. Med. 332:1118-1124; 1995.
24. Kordower, J. H.; Emborg, M. E.; Bloch, J.; Ma, S. Y.; Chu, Y.; Leventhal, L.; McBride, J.; Chen, E. Y.; Palfi, S.; Roitberg, B. Z.; Brown, W. D.; Holden, J. E.; Pyzalski, R.; Taylor, M. D.; Carvey, P.; Ling, Z.; Trono, D.; Hantraye, P.; Deglon, N.; Aebischer, P. Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease. Science 290:767-773; 2000.
25. Lehtonen, E.; Bonnaud, F.; Melas, C.; Lubansu, A.; Malgrange, B.; Chtarto, A.; Velu, T.; Brotchi, J.; Levivier, M.; Peschanski, M.; Tenenbaum, L. AAV2 vectors mediate efficient and sustained transduction of rat embryonic ventral mesencephalon. Neuroreport 13:1503-1507; 2002.
26. Levivier, M.; Dethy, S.; Rodesch, F.; Peschanski, M.; Vandesteene, A.; David, P.; Wilder, D.; Goldman, S.; Claes, T.; Biver, F.; Liesnard, C.; Goldman, M.; Hildebrand, J.; Brotchi, J. Intracerebral transplantation of fetal ventral mesencephalon for patients with advanced Parkinson's disease: Methodology and 6-month to 1-year follow-up in 3 patients. Stereotact. Funct. Neurosurg. 69:99-111; 1997.
27. Lo, W. D.; Qu, G.; Sferra, T. J.; Clark, R.; Chen, R.; Johnson, P. R. Adeno-associated virus-mediated gene transfer to the brain: Duration and modulation of expression. Hum. Gene Ther. 20:201-213; 1999.
28. Mahalik, T. J.; Hahn, W. E.; Clayton, G. H.; Owens, G. P. Programmed cell death in developing grafts of fetal substantia nigra. Exp. Neurol. 129:27-36; 1994.
29. Mandel, R. J.; Spratt, S. K.; Snyder, R. O.; Leff, S. E. Midbrain injection of recombinant adeno-associated virus encoding rat glial cell line-derived neurotrophic factor protects nigral neurons in a progressive 6-hydroxydopamine-induced degeneration model of Parkinson's disease in rats. Proc. Natl. Acad. Sci. USA 94:14083-14088; 1997.
30. Mastakov, M. Y.; Baer, K.; Symes, C. W.; Leichtlein, C. B.; Kotin, R. M.; During, M. J. Immunological aspects of recombinant adeno-associated virus delivery to the mammalian brain. J. Virol. 16:8446-8454; 2002.
31. McCown, T. J.; Xiao, X.; Li, J.; Breese, G. R.; Samulski, R. J. Differential and persistent expression patterns of CNS gene transfer by adeno-associated virus (AAV) vector. Brain Res. 713:99-107; 1996.
32. Morrish, P. K.; Sawle, G. V.; Brooks, D. J. An [18F]dopa-PET and clinical study of the rate of progression in Parkinson's disease. Brain 119:585-591; 1996.
33. Ostenfeld, T.; Tai, Y. T.; Martin, P.; Deglon, N.; Aebischer, P.; Svendsen, C. N. Neurospheres modified to produce glial cell line-derived neurotrophic factor increase the survival of transplanted dopamine neurons. J. Neurosci. Res. 69:955-965; 2002.
34. Peschanski, M.; Defer, G.; N'Guyen, J. P.; Ricolfi, F.; Monfort, J. C.; Remy, P.; Geny, C.; Samson, Y.; Hantraye, P.; Jeny, R. Bilateral motor improvement and alteration of L-DOPA effect in two patients with Parkinson's disease following intrastriatal transplantation of fetal ventral mesencephalon. Brain 117:487-499; 1994.
35. Piccini, P.; Brooks, D. J.; Björklund, A.; Gunn, R. N.; Grasby, P. M.; Rimoldi, O.; Brundin, P.; Hagell, P.; Rehncrona, S.; Widner, H.; Lindvall, O. Dopamine release from nigral transplants vizualized in vivo in a Parkinson's patient. Nat. Neurosci. 2:1137-1140; 1999.
36. Przedborski, S.; Levivier, M.; Jiang, H.; Ferreira, M.; Jackson-Lewis, V.; Donaldson, D.; Togasaki, D. M. Dose-dependent lesions of the dopaminergic nigrostriatal injection of 6-hydroxydopamine. Neuroscience 67:631-647; 1995.
37. Qing, K.; Khuntirat, B.; Mah, C.; Kube, D. M.; Wang, X. S.; Ponnazhagan, S.; Zhou, S.; Dwarki, V. J.; Yoder, M. C.; Srivastava, A. Adeno-associated virus type 2-mediated gene transfer: Correlation of tyrosine phosphorylation of the cellular single-stranded D sequence-binding protein with transgene expression in human cells in vitro and murine tissues in vivo. J. Virol. 72:1593-1599; 1998.
38. Sauer, H.; Oertel, W. H. Progressive degeneration of nigrostriatal dopamine neurons following intrastriatal terminal lesions with 6-hydroxydopamine: A combined retrograde tracing and immunocytochemical study in the rat. Neuroscience 59:401-415; 1996.
39. Schierle, G. S.; Hansson, O.; Leist, M.; Nicotera, P.; Widner, H.; Brundin, P. Caspase inhibition reduces apoptosis and increases survival of nigral transplants. Nat. Med. 5:97-100; 1999.
40. Tenenbaum, L.; Jurysta, F.; Stathopoulos, A.; Puschban, Z.; Melas, C.; Hermens, W. T.; Verhaagen, J.; Pichon, B.; Velu, T.; Levivier, M. Tropism of AAV-2 vectors for neurons of the globus pallidus. Neuroreport 11:2277-2283; 2000.
41. Ungerstedt, U.; Arbuthnott, G. W. Quantitative recording of rotational behavior in rats after 6-hydroxy-dopamine lesions of the nigrostriatal dopamine system. Brain Res. 24:485-493; 1970.
42. Verwer, R. W.; Hermens, W. T.; Dijkhuizen, P.; Ter Brake, O.; Baker, R. E.; Salehi, A.; Sluiter, A. A.; Kok, M. J.; Muller, L. J.; Verhaagen, J.; Swaab, D. F. Cells in human postmortem brain tissue slices remain alive for several weeks in culture. FASEB J. 16:54-60; 2002.
43. Wu, P.; Phillips, M. I.; Bui, J.; Terwilliger, E. F. Adeno-associated virus vector-mediated transgene integration into neurons and other nondividing cell targets. J. Virol. 72:5919-5926; 1998.
44. Xiao, X.; Li, J.; Samulski, R. J. Production of high-liter recombinant adeno-associated virus vectors in the absence of helper adenovirus. J. Virol. 72:2224-2232; 1998.
45. Zolotukhin, S.; Byrne, B. J.; Mason, E.; Zolotukhin, I.; Potter, M.; Chesnut, K.; Summerford, C.; Samulski, R. J.; Muzyczka, N. Recombinant adeno-associated virus purification using novel methods improves infectious titer and yield. Gene Ther. 6:973-985; 1999.